Nevertheless, our research still had some limitations: 1) the sample size was not large enough; 2) sample specificity was not considered; 3) whether RRM2 was related to the sensitivity of HCC to chemotherapy drugs has been unclear; 4) more detailed molecular mechanisms needed to be elucidated. The gene discussed is RRM2; the disease is hepatocellular carcinoma.